Yarmela Pavlovic, a partner with the global law firm of Hogan Lovells, takes a closer look at the FDA's final guidance document on mobile medical apps, pointing out some key changes and issues that may need more clarity.
Yarmela Pavlovic, part of the Hogan Lovells law firm's Life Sciences practice, takes a look at the key issues facing mHealth advocates as we await the FDA's final draft on mobile medical apps regulations.